| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 |
| filingDate |
2012-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50c252c52c202abead3d405200af6afa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2a427e78e4d6e10d8c167726e00cb9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4922ab5274acfb6e561f96b8ff90afc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eca7d656bb6e98bf2515c71594bd4d14 |
| publicationDate |
2017-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2012296622-C1 |
| titleOfInvention |
Tenofovir alafenamide hemifumarate |
| abstract |
A hemifumaiate form of 9-[(R>2-[[(S)-[[(S>1- (isopropoxycaibonyl)etJhyl]amino]phenoxyphosphinyl]m (tenofovir alafenamide), and antiviral therapy using tenofovir alafenamide hemifurnarate (e.g., anti-HTV and anti-HBV therapies). Formula (I). |
| priorityDate |
2011-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |